← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADDOCK LLC · Approved 1985-11-26

Drug application

FDA Application #

ANDA062613

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

Nystatin

Active ingredients

NYSTATIN

Dosage form

POWDER

Route

ORAL

Marketing status

Discontinued

Sponsor

PADDOCK LLC

First approval

1985-11-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown